Page last updated: 2024-08-25

buparvaquone and sirolimus

buparvaquone has been researched along with sirolimus in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, W; Dobbelaere, D; Eichhorn, M; Galley, Y; Glaser, I; Hagens, G1

Other Studies

1 other study(ies) available for buparvaquone and sirolimus

ArticleYear
Jun NH2-terminal kinase is constitutively activated in T cells transformed by the intracellular parasite Theileria parva.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, May-13, Volume: 94, Issue:10

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antiprotozoal Agents; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Enzyme Activation; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Indoles; JNK Mitogen-Activated Protein Kinases; Kinetics; Lymph Nodes; Lymphocyte Activation; Maleimides; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinases; Naphthoquinones; Polyenes; Protein Kinase C; Protein Kinases; Receptor-CD3 Complex, Antigen, T-Cell; Sirolimus; T-Lymphocytes; Tacrolimus; Theileria parva

1997